Stanford University
Showing 541-550 of 1,077 Results
-
Matthew Fitzgerald, PhD
Associate Professor of Otolaryngology - Head & Neck Surgery (OHNS)
Current Research and Scholarly InterestsMy research encompasses several translational projects. One focus is to modify the routine audiologic test battery such that it places equal weight on hearing acuity and hearing function. This work includes measures of speech in noise, or electrophysiologic responses such as the FFR. I also explore tools to better assess and maximize performance in users of hearing aids and cochlear implants. Finally, I am also investigating the benefits of telemedicine, and new treatments for tinnitus.
-
Peter Fitzgerald, MD, PhD
Professor (Research) of Medicine (Cardiovascular), Emeritus
BioDr. Peter Fitzgerald is the Director of the Center for Cardiovascular Technology and the Cardiovascular Core Analysis Laboratory (CCAL) at Stanford University School of Medicine. He is an interventional cardiologist and holds a PhD in engineering. He is a professor in both the Department of Medicine and the Department of Engineering (by courtesy) at Stanford.
Dr. Fitzgerald has led or participated in more than 175 clinical trials, has published more than 550 manuscripts and book chapters, and lectures worldwide. Over the past two decades, he has trained more than 150 postdoctoral researchers in engineering and medicine. Most recently, Dr. Fitzgerald completed two years of study toward a master’s degree focused on machine learning and agentic principles supporting AI.
Dr. Fitzgerald has been a principal founder of 24 medical startups in the San Francisco Bay Area and has transitioned 17 of them to large medical device companies. He serves on several boards of directors and advises dozens of medical device startups, as well as multinational healthcare companies, on the design and development of new diagnostic and therapeutic devices in the cardiovascular arena. In 2001, Dr. Fitzgerald was part of the founding team of LVP Capital, a venture firm focused on medical device and biotechnology startups in San Francisco. In 2010, he co-founded Triventures, an early-stage medical technology fund with offices in Palo Alto and Tel Aviv.
